US Stock MarketDetailed Quotes

TRVI Trevi Therapeutics

Watchlist
  • 6.500
  • -0.025-0.38%
Close Mar 28 16:00 ET
  • 6.325
  • -0.175-2.70%
Post 20:01 ET
628.43MMarket Cap-13.83P/E (TTM)

Trevi Therapeutics Key Stats

Trevi Therapeutics Q4 2024 Earnings Date

Currency:USDMar 18, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-0.12
-0.11
+0.01
Beat Est.
-54.82%
-37.50%
+11.08%
Net Income
--
-11.42M
--
-45.95%
Strong Buy

Mar 20, 2025

Trevi Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
Mar 18, 20252024/Q40.000 / 0.000--
Nov 6, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
Mar 18, 20252024/Q40.000 / 0.000--
Nov 6, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Trevi Therapeutics Earnings Reports

Read more

Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 20, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data